Characterising cause of death among people treated for drug-susceptible TB in India.
作者信息
Cox S R, Padmapriyadarsini C, Mave V, Seth B, Thiruvengadam K, Gaikwad S, Sahasrabudhe T R, Sane M, Tornheim J A, Shrinivasa B M, Lokhande R, Barthwal M S, Shivakumar S V B Y, Krishnan S, Santhappan R, Kinikar A, Kakrani A L, Paradkar M, Bollinger R C, Sekar K, Gupte A N, Hanna L E, Gupta A, Golub J E
机构信息
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Indian Council of Medical Research-National Institute of Research in Tuberculosis, Chennai, India.
出版信息
Int J Tuberc Lung Dis. 2023 Jan 1;27(1):78-80. doi: 10.5588/ijtld.22.0454.
Abstract
摘要
相似文献
1
Characterising cause of death among people treated for drug-susceptible TB in India.印度耐多药结核病患者死亡原因的特征分析。
Int J Tuberc Lung Dis. 2023 Jan 1;27(1):78-80. doi: 10.5588/ijtld.22.0454.
2
Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.利用言语尸检确定耐多药结核病治疗期间的根本死因，印度。
Emerg Infect Dis. 2018 Mar;24(3):478-484. doi: 10.3201/eid2403.171718.
3
Why are people dying due to tuberculosis? A study from Alappuzha District, Kerala, India.为什么人们会死于肺结核？来自印度喀拉拉邦阿拉普扎县的一项研究。
Indian J Tuberc. 2019 Oct;66(4):443-447. doi: 10.1016/j.ijtb.2018.05.001. Epub 2018 May 18.
4
Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011-2020.2011 - 2020年韩国国家结核病登记处与统计数据在结核病治疗期间死亡原因估计上的差异
J Infect Public Health. 2025 May;18(5):102723. doi: 10.1016/j.jiph.2025.102723. Epub 2025 Feb 26.
5
Tuberculosis mortality in a rural population from South India.印度南部农村人口的结核病死亡率
Indian J Tuberc. 2016 Apr;63(2):100-5. doi: 10.1016/j.ijtb.2015.07.005. Epub 2016 Jun 4.
6
Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.印度西部半城市和农村地区药物敏感肺结核患者的费用。
Infect Dis Poverty. 2020 Oct 19;9(1):144. doi: 10.1186/s40249-020-00760-w.
7
Survival of tuberculosis patients treated under DOTS in a rural Tuberculosis Unit (TU), south India.印度南部一家农村结核病防治单位（TU）中接受直接观察短程治疗（DOTS）的结核病患者的生存率。
Indian J Tuberc. 2008 Apr;55(2):64-9.
8
Use of Death Certificates to Identify Tuberculosis-Related Deaths in Washington State.利用死亡证明确定华盛顿州与结核病相关的死亡情况。
J Public Health Manag Pract. 2017 Mar/Apr;23(2):e12-e15. doi: 10.1097/PHH.0b013e3182aaa1d8.
9
Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.抗逆转录病毒治疗开始前后结核病的发病率和死亡率：印度一项HIV队列研究
J Int AIDS Soc. 2014 Dec 9;17(1):19251. doi: 10.7448/IAS.17.1.19251. eCollection 2014.
10
Counting the lives saved by DOTS in India: a model-based approach.计算印度直接观察短程治疗（DOTS）挽救的生命：一种基于模型的方法。
BMC Med. 2017 Mar 3;15(1):47. doi: 10.1186/s12916-017-0809-5.
本文引用的文献
1
Long-term Survival of Treated Tuberculosis Patients in Comparison to a General Population In South India: A Matched Cohort Study.印度南部治疗结核病患者与普通人群的长期生存比较：一项匹配队列研究。
Int J Infect Dis. 2021 Sep;110:385-393. doi: 10.1016/j.ijid.2021.07.067. Epub 2021 Jul 29.
2
Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India.印度浦那的糖尿病与结核病治疗结果
Open Forum Infect Dis. 2021 Mar 4;8(4):ofab097. doi: 10.1093/ofid/ofab097. eCollection 2021 Apr.
3
Tuberculosis case fatality in India: a systematic review and meta-analysis.印度的结核病病死率：系统评价和荟萃分析。
BMJ Glob Health. 2020 Jan 20;5(1):e002080. doi: 10.1136/bmjgh-2019-002080. eCollection 2020.
4
Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis.结核病治疗患者的长期全因死亡率：系统评价和荟萃分析。
Lancet Infect Dis. 2019 Oct;19(10):1129-1137. doi: 10.1016/S1473-3099(19)30309-3. Epub 2019 Jul 16.
5
Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam.肺结核患者治疗后的死亡率：越南 10964 例患者的前瞻性队列研究。
Clin Infect Dis. 2019 Apr 8;68(8):1359-1366. doi: 10.1093/cid/ciy665.
6
Nationwide Mortality Studies To Quantify Causes Of Death: Relevant Lessons From India's Million Death Study.全国死亡率研究以量化死因：印度百万死亡研究的相关经验教训。
Health Aff (Millwood). 2017 Nov;36(11):1887-1895. doi: 10.1377/hlthaff.2017.0635.
7
Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study.印美医学合作结核病研究队列（CTRIUMPH）：一项多中心前瞻性观察性研究的方案
BMJ Open. 2016 Feb 25;6(2):e010542. doi: 10.1136/bmjopen-2015-010542.
8
DOTS for TB relapse in India: A systematic review.印度结核病复发的直接观察短程疗法：一项系统评价。
Lung India. 2012 Apr;29(2):147-53. doi: 10.4103/0970-2113.95320.
Zotero 插件